Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660553 · ClinicalTrials.gov registry record · Phase 4
Simplified Insulin Regimen for the Elderly
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT03660553 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 7 participants.
The verdict
NCT03660553, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
Basal-bolus insulin therapy, which includes one injection of long acting insulin and three injections of short acting insulin is the most commonly used insulin treatment. However, many older patients find the basal-bolus insulin regimen hard to manage because it involves 4 injections and 4 blood glucose tests each day. It is possible that a simplified treatment that involves one injection of long acting insulin daily and two blood glucose tests daily might be equally effective. This simplified regimen, if effective, would be easier to use and might result in less errors. Therefore, the investigators want to conduct this study to compare using a single daily injection of basal insulin with the usual basal-bolus insulin regimen in elderly patients (age \>65 years) with type 2 diabetes.
Interventions
- DRUG Insulin Glargine
- DRUG Insulin Lispro
- DRUG Insulin Aspart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03660553
The ClinicalTrials.gov registry entry for NCT03660553 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Insulin Glargine is the first listed.
NCT03660553 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03660553 about?
NCT03660553 is a clinical study titled "Simplified Insulin Regimen for the Elderly". Basal-bolus insulin therapy, which includes one injection of long acting insulin and three injections of short acting insulin is the most commonly used insulin treatment. However, many older patients find the basal-bolus insulin regimen hard to manage because it involves 4 injections and 4 blood glu...
What is the current status of trial NCT03660553?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2018-10-10. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03660553?
The interventions under investigation include: Insulin Glargine (DRUG), Insulin Lispro (DRUG), Insulin Aspart (DRUG).
Who is sponsoring clinical trial NCT03660553?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.